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Received April 11, 2014; accepted August 6, 2014AbstractBackground: Light injury to photoreceptor cells and retinal pigment epithelium may lead to oxidative stress and irreversible degeneration of
retina, especially degeneration of the high energy-demanded macula. The model of retinal photodamage could be applied to age-related macular
degeneration and other degenerative retinal diseases for exploring new treatments. Based on broadly investigated induced pluripotent stem cells
(iPSC) in the field of retinal degeneration, we aimed to clarify further how the interaction progresses between iPSC-conditional medium (CM)
and light-damaged retina.
Methods: iPSCs were generated from murine embryonic fibroblasts of C57/B6 mice by retroviral transfection of three factors: Oct4, Sox2, and
Klf4. Cytokine array was performed to analyze the components of CM. SpragueeDawley rats receiving white light exposure to retina were
viewed as an animal model of light injury. The rats were divided into four subgroups: light-injured rats receiving intravitreal injection of iPSC-
CM, apoptotic iPSC-CM, or sodium phosphate buffer (PBS); and a control group without light damage. The electroretinography and thickness of
outer nuclear layer were measured to document the therapeutic effects in each condition. Apoptosis arrays for detecting annexin Vand caspase 3
were performed in the retinal tissues from each group.
Results: Murine embryonic fibroblasts were induced into iPSCs and expressed the marker genes similar to embryonic stem cells. These iPSCs
can differentiate into Embryoid bodies (EBs), three germ layers in vitro and develop teratoma in severe combined immunodeficiency mice. The
quantitative polymerase chain reaction of our iPSC-CM showed significantly elevated fibroblast growth factor-2, glial cell-derived neurotrophic
factor, and insulin-like growth factor-binding proteins-1, -2, and -3. Compared to rats without photodamage, the light-injured rats receiving
iPSC-CM had less reduction of outer nuclear layer thickness on Day 21 than other groups treated with either PBS or apoptotic iPSC-CM. In the
same animal model, both a- and b-waves of electroretinography measurement in the group treated with iPSC-CM were significantly maintained
compared to the control group and others with apoptotic iPSC-CM or PBS treatment. The apoptosis assay also demonstrated lower levels of
annexin V and caspase 3 in the group with iPSC-CM treatment than in other groups presenting increasing apoptotic markers.
Conclusion: The conditional medium of iPSCs contains plenty of cytoprotective, immune-modulative and rescue chemicals, contributing to the
maintenance of neuronal function and retinal layers in light-damaged retina compared with apoptotic iPSC-CM and PBS. The antiapoptotic
effect of iPSC-CM also shows promise in restoring damaged neurons. This result demonstrates that iPSC-CM may serve as an alternative to cell
therapy alone to treat retinal light damage and maintain functional and structural integrity of the retina.
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Retina degeneration generally leads to visual impairment.
Its major causes are associated with old age, light injury,
oxidative stress, and ocular trauma. Age-related macular
degeneration (AMD) is the most important and the most
challenging issue to deal with, because it involves the
degeneration of retinal pigment epithelium (RPE) and photo-
receptor cells. AMD is clinically divided into two categories:
dry and wet types. There are several therapies for the treatment
of wet AMD, the neovascular and more severe type, including
using argon laser photocoagulation to treat degeneration-
associated choroidal neovascularization (CNV). The thera-
peutic aim is to destroy the neovascular membrane by
photocoagulation, but such treatment also destroys the over-
lying retina, with a resultant scotoma.
Photodynamic therapy for wet AMD has recently been
approved in the USA. It utilizes a 10-minute intravenous
infusion of verteporfin (a photosensitizing drug), followed
by diode laser (689 nm) exposure to destroy the neo-
vascularization. Vascular endothelial growth factor (VEGF) has
been identified in recent decades as a pivotal treatment surro-
gate for CNV. However, the benefits of utilizing anti-VEGF
agents to prevent CNV recurrence or occult pre-CNV are still
under debate. Moreover, subfoveal fibrosis will also develop or
progress in neovascular AMD even though patients have no
significant subfoveal hemorrhage and have already been treated
with anti-VEGF agents. The presentation of antifibrotic thera-
peutics may be beneficial in reducing the incidence of sub-
retinal fibrosis1; however, none of the types of treatment
mentioned above are the perfect solution to wet AMD.
Recent novel techniques have been able to generate
induced pluripotent stem cells (iPSCs) from mouse and human
adult somatic cells, such as fibroblasts, via the retrovirus-
mediated transfection of four transcription factors, Oct3/4,
Sox2, c-Myc, and Klf4.2e5 iPSCs have been further demon-
strated to be indistinguishable from embryonic stem (ES) cells
in morphology, proliferative abilities, surface antigens, gene
expression, epigenetic status of pluripotent cell-specific genes,
and telomerase activity.4,5 iPSCs share the same features as ES
cells and are capable of self-renewal and differentiation into
three germ layers, offering potential for clinical cell therapies
and tissue engineering.2 Furthermore, iPSCs can be derived
from the patient's own somatic cells to avoid potential immune
response and ethical concerns. As a result, patient-derived
iPSC therapy can provide better function in recipients than
available ES cell lines can. Therefore, iPSCs are regarded as
an excellent candidate for cell therapy and used in autologous
transplantation without the risk of rejection.
Recent studies have shown that iPSCs present the capability
of multilineage differentiation and further reduce the severity of
cerebral ischemic injury in rats, endotoxin-induced acute lung
injury and bleomycin-induced lung inflammation and fibrosis
in mice.6e9 We also found that both four-gene iPSCs, three-
gene iPSCs, and their conditional medium (iPSC-CM) could
reduce the level of inflammatory cytokines and chemokines in
animals and thus decrease the inflammatory and fibroticreaction.8,9 Essentially, administration of iPSC-CM will not
lead to the tumorigenesis that has been of greatest concern in
stem cell therapy.
The treatment of light-damaged retina with iPSC-CM had
not been commonly discussed before. In this study, our pur-
pose was to demonstrate that iPSC-CM could suppress outer
nuclear layer (ONL) thinning and recover impaired cellular
function monitored by electroretinography (ERG) in light-
injured murine retina. We hypothesized that the cytokines or
chemokines in iPSC-CM might be beneficial to the light-
damaged photoreceptors in the retina. Our findings may pro-
vide an alternative therapeutic strategy against light-induced
retinal damage.
2. Methods2.1. iPSCs cultured from murine embryonic fibroblastsC57BL/6 mice were used in this study and all procedures
involving animals were approved by the Animals Committee
of the Taipei Veterans General Hospital. Our murine iPSCs
were generated with only three introduced factors (Oct4/Sox2/
Klf4) to avoid oncogene c-Myc (non-c-Myc iPSC). These
iPSCs were generated from murine embryonic fibroblasts
(MEFs) derived from 13.5-day-old embryos of C57/B6 mice.
The reprogrammed iPSCs without c-Myc were transducted by
retroviral vectors encoding three factors, Oct4, Sox2, and
Klf4, as described previously.10 Briefly, undifferentiated iPSCs
were generally cultivated and expanded on mitotically inert
MEFs (50,000 cells/cm2) in six-well culture plates (BD
Technology, Triangle Park, NC, USA) with 0.3% leukemia
inhibitory factor in an iPSC medium consisting of Dulbecco's
modified Eagle's medium supplemented with 15% fetal bovine
serum (FBS), 100 mM minimal essential medium nonessential
amino acids, 0.55 mM 2-mercaptoethanol, and antibiotics.
Every 3e4 days, colonies were separated with 0.2% collage-
nase IV, dissociated into single cells with 0.025% trypsin and
0.1% chicken serum in sodium phosphate buffer (PBS), and
re-plated onto MEFs. The non-c-Myc iPSCs presented higher
pluripotency and could be differentiated into three germ lines,
including astroglial (neuro-ectodermal), osteogenic (meso-
dermal), and hepatocyte-like (endodermal) lineage cells.10
For induction of apoptosis, iPSCs were treated with
200 mM H2O2 for 18 hours. The definition of apoptosis was
first based on a distinct sequence of morphologic features by
microscopy (shrinkage of the cell and the nucleus), and further
confirmed by caspase 3 activity and annexin V. After 6 hours
of H2O2 treatment, the condition medium was collected for
following experiment.2.2. Light exposure and intravitreal treatmentAll experiments were conducted in accordance with the
Animal Care and Use Committee guidelines and in compliance
with the ARVOStatement for theUse of Animals in Ophthalmic
and Vision Research. Four-week-old, male SpragueeDawley
rats, each weighing 150e250 g, were raised in plastic cages in a
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cyclic light (5 lux, 12 hours on/off). All animals had free access
to food and water. Rats were anesthetized with intramuscular
delivery of an equal-volume mixture of 2% lidocaine (Xylo-
caine; Astra, S€odert€alje, Sweden) and 50 mg/mL ketamine
(Ketalar; Parke-Davis, Morris Plains, NJ, USA) by 0.15 mL/kg.
Light exposure murine models were performed as previously
described.11 The rats were exposed to 10,000 lux of white light
for 2 hours from 9:00AM to 11:00AM in a Plexiglas cage with
mirrors on the lateral sides and the floors. Before intense light
illumination, rats were dark adapted for 24 hours. Tropicamide
(1% Mydriacyl; Alcon Laboratories, Hemel Hempstead, Herts,
UK) was used to dilate the pupils before light exposure. The
temperature of the environment was kept at 24C. After 2 hours'
exposure to light, the rats were maintained under dim cyclic
light (5 lux, 12 hours on/off). After the rats were anesthetized,
their corneas were anesthetized with a drop of 0.5% propar-
acaine hydrochloride (Alcaine; Alcon-Couvreur, Puurs,
Belgium), pupils were dilated with 1% tropicamide and then the
eyes were gently protruded with a rubber sleeve. Intravitreal
injection of different remedies was performed 1 mm behind the
limbus with a 33-gauge blunt-tip needle (Hamilton, Reno, NV,
USA) and leaving the needle for 1minute to reduce the reflux. A
total of 24 rats were used in this study andwere divided into four
subgroups: normal control without light exposure; intravitreal
injection of iPSCs and their condition medium; intravitreal in-
jection of apoptotic iPSCs and their condition medium; and
intravitreal injection of PBS after light exposure. The animals
were sacrificed by carbon dioxide suffocation 21 days after the
start of light exposure, and the eyes were then enucleated for
histopathologic and immunohistochemical analyses.2.3. Investigation of cytokinesTo identify components of each CM, 1 mL of CM was
analyzed by the Human Cytokine Array Kit (Panel A; R&D
Systems, Wiesbaden-Nordenstadt, Germany) according to the
manufacturer's instructions. The pixel density was identified
using ImageJ software (NIH, Bethesda, MD, USA). Signals
were normalized to the average of the positive controls on
each array and the background was eliminated.2.4. Measurement of ONL thicknessTo compare the trophic effect of different CMs, the thick-
ness of the outer nuclear layer in photodamaged murine retina,
treated under variable conditions, was directly measured on
histologic section on Day 21 after intravitreal injection. After
removing the contents including cornea, lens, and vitreous, the
remaining parts of the eye were fixed in 4% (W/V) para-
formaldehyde in 100 mM PBS, pH 7.3 overnight at 4C, before
cryoprotection in sucrose and being mounted in an optimal
counting temperature compound (OCT Tissue-Tek; Sakura,
Alphen aan den Rijn, The Netherlands). Retinal sections were
then cut at 0.5-mm thickness along the vertical meridian using
a cryostat. The sections were stained with hematoxylin and
eosin (H&E) and examined by light microscope. Six differentmeasurements were recorded in each harvested retina, and the
average was calculated at the same time.2.5. ERGThe animals were kept in dark for at least 1 day overnight,
and ERGs were recorded at 1 day, 3 days, 7 days, 14 days, or
21 days after light exposure, as previously described, with some
modifications.12 Briefly, the anesthesia of animals was done
with intramuscular injections of 50mg/kg ketamine/0.15mg/kg
lidocaine, their corneas were anesthetized with a drop of 0.5%
proparacaine hydrochloride, and 1% tropicamide was used to
dilate the pupils. The rats were placed on a heating pad that
maintained their body temperature at 35e36C during the
experiment. The ground electrode was a subcutaneous needle
through the tail, and the reference electrodewas placed between
the eyes subcutaneously. The contact lens electrodes were put
over the cornea. Responses were amplified differentially, light
pulses of 800 cd/m2, bandpass filtered at 0.3e500 Hz, digitized
at 0.25e0.5-ms intervals by a commercial system (RETIport
ERG laptop version, Acrivet, Germany), and stored for pro-
cessing. The implicit times of the a- and b-waves were
measured from the onset of stimuli to the peak of each wave.
The a-wave amplitude was measured from the baseline to its
trough, and b-wave amplitude was determined from the trough
of the a-wave to the peak of the b-wave.2.6. Caspase 3 activity and annexin VThe cell lysates from the retina of the animal model were
harvested for apoptotic assay. Retinal caspase-3 activity was
identified with a commercial colorimetric kit (EnzChek Caspase
3 Assay Kit # 1; Molecular Probes, Inc. Eugene, OR, USA) ac-
cording to themanufacturer's instructions. Briefly, equal aliquots
of retinal homogenate were heated at 37C for 30 minutes with
caspase-3-specific substrate Z-DEVD-AMC in the kit reaction
buffer. The absorbance of each sample was read at 441 nm and
the color reaction shown was directly proportional to caspase-3
activity levels. Chick retinas (embryonic stage 11) were used as
positive control of caspase-3 activity. Results were expressed as
the percentage change in the absorbance. For retinal cells,
apoptosis was assessed with flow cytometry using an annexin V-
fluorescein isothiocyanate apoptosis detection kit (BD Tech-
nology) according to the manufacturer's instructions. Briefly,
cells were washed, pooled, and suspended in 500 mL binding
buffer, followed by addition of 5 mL annexin V-fluorescein iso-
thiocyanate. Cells were incubated at room temperature avoiding
light for 15 minutes, and analyzed with flow cytometry (Beck-
man Coulter EPICSXL/MCL). Viable cells were unstained with
annexin V, while apoptotic cells were stained with annexin V.2.7. Statistical analysisThe data are expressed as mean ± standard error of the
mean. Differences between groups were compared using
Student t test. Values of p < 0.05 were considered to indicate
statistical significance.
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investigation of mRNA expression level in CMWe hypothesized that if components of CM from iPSCs
support survival of retinal neurons after light injury, growth or
neurotrophic factors should be found therein. Compared with
the murine fibroblasts, components of CM from iPSCs showed
significantly elevated vital cytokines for neurons by quantita-
tive polymerase chain reaction, including fibroblast growth
factor (FGF)-2, glial cell-derived neurotrophic factor (GDNF),
insulin-like growth factor-binding protein-1 (IGFBP-1),
IGFBP-2, and IGFBP-3 (Fig. 1). All of these increased cyto-
kines potentially enhance retinal neurons to survive against
apoptosis.3.2. Effects of iPSC-CM in the histopathology and
thickness of light-injured murine retinaThe iPSC-CMwas able to maintain structure of light-injured
murine retina, as assessed by histopathology. Fig. 2A-I shows
normal histology of murine retina without light exposure in the
H&E stain. Light exposure can cause significant damage and
apoptosis to retinal cells. These light-injury consequences
included apoptosis, edema, and degeneration of RPE cells. To
explore the role of iPSC with CM in photodamaged retina, we
compared retinal sections from light-injured rats that had un-
dergone PBS, apoptotic iPSC-CM, and iPSC-CM treatment.
These rats were sacrificed on the 21st day after treatment, at
which time all retina sections were evaluated with H&E stain.
Rat retinas that received the intravitreal injection of apoptotic
iPSC-CM (Fig. 2A-III) showed no improvement in the severity
of retina damage induced by light exposure as compared with
intravitreal injection of PBS (Fig. 2A-II). In contrast, rats thatFig. 1. Factors in conditional medium analyzed by quantitative polymerase
chain reaction. The quantitative polymerase chain reaction for detecting cy-
tokines in conditioned medium (CM) of induced pluripotent stem cells (iPSCs)
showed significantly increased expression of fibroblast growth factor-2 (FGF-
2), glial cell-derived neurotrophic factor (GDNF), and insulin-like growth
factor-binding proteins (IGFBP)-1, IGFBP-2, and IGFBP-3, comparing with
that from murine fibroblast. Statistically significant results are indicated by an
asterisk (*).received the iPSC-CM treatment showed improvement of
retinal damage in the retinal layers (Fig. 2A-IV).3.3. iPSC-CM suppressed ONL thinning in light-injured
retinaTo evaluate the trophic effect of iPSC-CM on light-injured
retinas of rats, we measured the change of ONL thickness in
six areas on the 21st day after light exposure. The ONL
thickness of light-injured retina in PBS or apoptotic iPSC-CM
rats were significantly reduced, as compared to that in rats
receiving no light exposure (Fig. 2B). As shown in Fig. 2C, the
average retina thickness in normal rats without light injury was
117.5 mm. Compared to the average ONL thicknesses of
photodamaged retinas under iPSC-CM (88.33 mm), apoptotic
iPSC-CM (70.3 mm) and PBS (70.1 mm) treatment on the 21st
day, we found that the iPSC-CM treatment was able to
significantly suppress ONL thinning in the light-injured rats.
These findings indicate restorative effects on light-injured
murine retina following treatment with iPSC-CM.3.4. iPSC-CM recovered impaired ERGRPE is essential for maintaining the physiology of the
neurosensory retina. Injection of iPSC-CM may restore the
function of damaged neurons. The amplitudes of ERG
decreased in several retinal dysfunctions, such as AMD and
light-damaged retina. Light exposure to murine retina on the
first day led to significant reduction in average a- and b-wave
amplitudes ratio (0.4 and 0.4, respectively; Fig. 3) in photo-
damage rats than normal rats without light exposure. We
wanted to investigate the therapeutic effect of intravitreal
iPSC-CM application on light-induced retinal dysfunction in
rats. The changes of ERG response were observed for 21 days
after light exposure (Fig. 3). Our findings showed that appli-
cation of iPSC-CM to light-exposed rats on the 14th day
significantly minimized the reduction of the average ampli-
tudes ratio in a-wave (0.68; Fig. 3A) and b-wave (0.6;
Fig. 3B), as compared to apoptotic iPSC-CM treatment in
light-exposed rats (0.45 and 0.41, respectively) and PBS
treatment in light-exposed rats (0.4 and 0.39, respectively).
Similar conditions were found on the 21st day in light-
injured rats. iPSC-CM application to light-exposed rats
significantly restored the reduction of average ratio in a-wave
(0.7) and b-wave (0.65) compared to apoptotic iPSC-CM
treatment in light-exposed animals (0.45 and 0.4, respec-
tively) and PBS treatment in light-exposed animals (0.4 and
0.39, respectively). There ERG data demonstrate that iPSC-
CM recovered the amplitude ratio of a- and b-wave in light-
injured murine retina.3.5. Apoptosis assay for light-injured murine retina in
different treatment protocolsLoss of neuronal cells from light damage to retina leads to
thinning and atrophy of retinal layers. To estimate the cell loss
under various rescuing treatments, we used apoptosis assay to
Fig. 2. Changes of outer nuclear layer thickness in normal control and each damaged retina under variable treatments. (A) Retinal tissue sections stained with
hematoxylin and eosin (H&E): normal retinal structure (A-I) and photodamaged retina treated with intravitreal PBS (A-II), conditioned medium (CM) of induced
apoptotic pluripotent stem cells (iPSCs) iPSC-CM (A-III), iPSC-CM (A-IV) injection after 21 days. The group treated with iPSC-CM (A-IV) showed maintained
outer nuclear layers and whole integrity layers of retina. (B) Retinal thickness was measured at six areas and then the data were averaged. Significant maintained
retinal thickness was noted between groups of photodamaged retina treated with iPSC-CM and those treated with PBS or apoptotic (a)iPSC. (C) iPSC-CM
successfully restored the retinal thickness significantly, as compared to PBS and aiPSC-CM groups, after 21 days. Statistically significant results are indicated
by an asterisk (*).
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change in retinal cells. The results of assay showed that after
light exposure, annexin V and caspase 3 were increasingly
detected in groups under treatment of PBS and apoptotic
iPSC-CM rather than in those receiving treatment of CM-
iPSCs or normal control (Fig. 4). This result revealed that
iPSC-CM was capable of maintaining the homeostasis of
damaged cells and preventing them from further injury and
apoptosis.
4. Discussion
Induced pluripotent stem cells and associated cell therapies
have been widely investigated in applications to retinal
degenerative diseases instead of ES cells to avoid ethical
problems, immune rejection, and shortage of cell sources.13e15
Although efficacy and safety of subretinally transplanted
iPSC-derived RPE graft has been guaranteed in a murine
retinal model of retinitis pigmentosa,16 directly transplanting
the iPSC-derived neural progenitor cells into the vitreous
cavity or subretinal space of patients with retinal degeneration
may lead to unpredictable cellular response and complications
from the intervention. The encouraging response of utilizingconditional medium for treatment of diseases may provide an
alternative safe and effective way to restore the dysfunctional
retina.17,18
As shown in published in-vivo and in-vitro studies, condi-
tional medium of stem cells contains several supplements
nourishing to cells, such as tissue inhibitor metalloproteinase-
1, secreted protein acidic and rich in cystein, ciliary neuro-
trophic factor (CNTF), basic FGF, and insulin-like growth
factor, which may inhibit photoreceptor and retinal ganglion
cell degeneration.17,19 At the same time, the supernatants from
light-induced retina may stimulate mesenchymal stem cells
(MSCs) to secret neurotrophin, such as basic FGF, CNTF, and
brain-derived neurotrophic factor, and reduce DNA fragmen-
tation, downregulate bax, and upregulate bcl-2 in the rat white
light-induced retinal injury model.20 These results indicate
that damaged retina may elevate rescue signals to recruit more
neurotrophins from the surrounding microenvironment for
survival, and that MSCs have the ability to provide such fac-
tors in abundance.
The cytokine array of our CM showed that factors, FGF-2,
GDNF, IGFBP-1, IGFBP-2, and IGFBP-3 were significantly
elevated compared with those from the MEFs. These factors
may prevent photoreceptors cells and retinal ganglion cells
Fig. 3. The average ratios of (A) a-wave and (B) b-wave amplitude in the four groups were measured on Days 1, 3, 7, 14, and 21. Conditioned medium (CM) of
induced pluripotent stem cells (iPSCs) restored the reduction of average ratio in a-wave and b-wave significantly, as compared to apoptotic (a)iPSC-CM and PBS
groups, on Days 14 and 21. Statistically significant results are indicated by an asterisk (*).
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rotrophic effects.17,19 Instead of protective effect in ischemic
retinal diseases,21 in-vivo and in-vitro evidence has shown
benefit of increased FGF-2 in photodamaged retina by protein
kinase B and extracellular signal-regulated kinase 1/2 (ERK 1/
2) pathway to support neurons.22e24 GDNF has also demon-
strated nourishing effect on and promising protection of retinal
neurons from apoptosis in murine models of ischemia, dia-
betes, and retinitis pigmentosa.25e27 This neuroprotection ef-
fect may be in part due to upregulated glutamate-aspartate
transporter.26 Finally, the IGFBP family is involved in conju-
gation with IGF and maintaining IGF concentration in target
tissues, meaning that upregulated IGFBPs could extend the
trophic effect of IGF on degenerating retinal neurons under
oxidative stress. Both markers of apoptosis: annexin V and
caspase 3, were elevated in neurons after photodamage in our
apoptosis assay, but only the group receiving iPSC-CM pre-
sented the same low grade of apoptosis as the control group
without light injury.Fig. 4. Levels of apoptosis markers in each treatment group. Apoptosis assay dem
conditioned medium (CM) of induced pluripotent stem cells (iPSCs) treatment, sim
were detected in the other two groups with apoptotic (a)iPSC-CM and PBS treatm
iPSC-CM and normal control are marked by *; statistically significant results betw
indicated by a hash sign (#).As reported in our previous study, subretinal delivery of Oct
4/SirT1 gene in advance could prevent following oxidative
stress damage from the light injury.28 In the current study,
giving iPSC-CM treatment to light-damaged mice in a
sequential process also showed promising benefit in main-
taining a more significant ratio of a- and b-waves in ERG than
other conditions. This means that the paracrine effect of iPSC-
CM may support the neurons to function normally and fight
against apoptosis, although they could not completely recover
from the light damage during our short study period. The a-
wave of ERG is composed of signals from photoreceptor cells,
bipolar cells, amacrine cells, and Muller cells; the cytopro-
tective effects of iPSC-CM may be attributed to all of the
closely interacting retinal neurons, not merely photoreceptor
cells. Both FGF receptor and CNTF receptor-a were found in
the photoreceptor cells that directly benefit from neuro-
trophins.29 A question remains: if CM was harvested from
different cell origins of iPSC, such as neuron-derived iPSC,
the paracrine effects might be more specific and multipliedonstrated lower levels of (A) annexin V and (B) caspase 3 in the group with
ilar to the control group. However, significantly increased apoptotic markers
ent. Statistically significant results between groups treated with PBS/apoptotic
een groups treated with iPSC-CM and those treated with PBS/aiPSC-CM are
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shown in our study. Otherwise, further experiments should be
carried out to confirm whether the iPSC-CM totally recovers
the function of photoreceptor cells after repeated therapies or
higher-dosage applications. The rescue signals from light-
damaged retinal cells should also be identified by microarray
or proteinomic methods, and the results of analysis could be
combined with CM to enhance the therapeutic effect.
AMD is the most important issue to investigate because it
involves the degeneration of RPE and photoreceptor cells. In
AMD, apart from oxidative stress of retinal photoreceptors and
subsequent surge of VEGF, another parallel pathogenesis is
inflammation that could be clinically suppressed by retro-
bulbar, peribulbar, or intravitreal injection of steroid. It is
believed that stem cells possess the ability immunomodulate in
microenvironments by several pathways, such as suppressing
T cells.30 If the immunomodulative effects also worked in
iPSCs-CM, they might be proved in the treatment of AMD to
eliminate local inflammation and prevent extension of cell
apoptosis. In the present study, we confirmed that apoptotic
iPSC-CM inhibits light-induced apoptosis, such as activation
of caspase 3 and annexin V, indicating that iPSC-CM is
capable of maintaining the homeostasis of damaged cells and
preventing them from further injury and apoptosis. This novel
findings may provide a new strategy for treating AMD.
The vitreous cavity is a relatively closed system. If iPSC-
CM were going to be used clinically, intravitreally injected
CM might affect all cells of the intraocular tissue. Thus, it is
important to clarify which route is most appropriate for de-
livery of the therapeutic medium and at which clinical stage of
retinal degeneration one should receive that therapy. In the
future, cell therapy combined with specific CM may provide
another therapeutic modality for treatment of degenerative
ocular diseases. However, because iPSC-CM is composed of
abundant neurotrophic factors, including VEGF,31 adverse and
mixed effects during delivery of such medium into ocular
tissue should be evaluated more definitely.
In conclusion, the conditional medium of iPSCs comprises
variable trophic factors, such as FGF-2, GDNF, and IGFBP,
that support retinal neurons and maintain neuronal function
with integrity of retinal structure after light damage. Further
detailed studies should be conducted to identify how to inte-
grate these components of CM into the treatment of clinical
diseases and their long-term efficacy.
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